OR WAIT null SECS
August 01, 2016
Quality, innovation, and new approval pathways open drug development options for the Chinese market, including injectable contract manufacturing.
While isolators may offer advantages in high-speed commercial manufacturing lines, RABS continues to be a flexible alternative solution for small-scale production of drugs for clinical use.
July 22, 2016
The company voluntarily recalls all lots of lyophilized HCG and sermorelin.
July 20, 2016
Gamma-stable fluoropolymers are an alternative material for single-use bags and assemblies in biopharmaceutical manufacturing.
July 19, 2016
FDA issued a warning letter to the Worthing, UK facility for cross contamination and microbial contamination cGMP violations.
July 06, 2016
Teligent is expanding its manufacturing and R&D complex in New Jersey.
July 02, 2016
Early planning for the integration of clean-in-place systems for equipment cleaning is key.
Aseptic spray drying provides an alternative to lyophilization as an enabling stabilization technology for parenteral biologic formulations.
June 22, 2016
The agency cited the company for sterile manufacturing violations.
June 03, 2016
Preheating pinch valves prevents drift in the volume of liquid dispensed.